Up-for-sale healthcare companies backer NetScientific PLC (LON:NSCI) has yet to receive any firm offers for any of the companies in its portfolio.
The company said it has received indications of interest in a potential acquisition of some of its portfolio companies although no binding or non-binding offers have emerged so far.
READ: NetScientific puts itself up for sale; says it’s feeling unloved by the market
At the end of the current calendar year, NetScientific is expected to have available cash resources of roughly £3mln. Next year and the year after the company expects to incur annual costs of roughly £2mln and thinks it will be obliged to pump around £5mln each year in its portfolio companies should those companies fail to raise external finance.
As a result, NetScientific continues to assess all of its strategic options, including seeking additional funding from its shareholders and taking material action to further reduce its costs, which may include seeking a delisting of its shares.